Text Size
25 studies found for:    Arnold-Chiari Malformation

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Arnold-Chiari Malformation
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Genetic Analysis of the Chiari I Malformation
Conditions: Syringomyelia;   Type I Arnold Chiari Malformation
Intervention:
2 Completed Establishing the Physiology of Syringomyelia
Conditions: Arnold Chiari Deformity;   Hydrocephalus;   Syringomyelia
Intervention:
3 Completed Duragen Versus Duraguard in Chiari Surgery
Condition: Chiari Malformation
Interventions: Procedure: Duraplasty with Duragen;   Procedure: Duraplasty with Duraguard
4 Recruiting A Prospective Natural History Study of Patients With Syringomyelia
Conditions: Syringomyelia;   Arnold Chiari Deformity
Intervention:
5 Active, not recruiting Magnetic Resonance Imaging (MRI) and Quantitative MR Cerebral Spinal Fluid (CSF) Flow Studies in Craniovertebral Junction Anomalies
Condition: Chiari Malformations
Intervention: Procedure: Dynamic cervical MRI
6 Recruiting Dural Graft Equivalent Comparison Trial
Condition: Chiari Malformation
Intervention: Procedure: decompression of Chiari malformation
7 Enrolling by invitation Chiari Study Looking at Use of Duragen Versus Duraguard
Condition: Chiari Malformation Type I
Intervention:
8 Recruiting Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
Condition: Venous Leg Ulcers
Interventions: Biological: HP802-247;   Biological: Vehicle
9 Completed Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
Condition: Actinic Keratosis
Intervention: Drug: PEP005 Topical gel
10 Completed
Has Results 		Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Condition: Hypogonadism
Intervention: Drug: testosterone matrix transdermal system
11 Completed Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Condition: Healthy
Intervention: Drug: testosterone
12 Completed
Has Results 		Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
13 Completed A 24 Week Open-Label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: ENA713;   Drug: Rivastigmine transdermal patch 15 cm2
14 Recruiting The Genetics of Chiari Type I Malformation
Condition: Chiari Type I Malformation
Intervention:
15 Recruiting Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects
Condition: Articular Cartilage Lesion of the Femoral Condyle
Interventions: Drug: co.don chondrosphere®;   Procedure: Microfracture
16 Completed
Has Results 		Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Condition: Keratosis
Intervention: Drug: imiquimod cream
17 Completed Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Condition: Healthy
Intervention: Drug: Rotigotine transdermal patch
18 Completed
Has Results 		Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Condition: Healthy Volunteers
Intervention: Drug: Rotigotine transdermal patch
19 Completed
Has Results 		A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
20 Recruiting Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel;   Drug: placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
† Indicates status has not been verified in more than two years